Cargando…
Severe Delayed Hemolysis Associated with Regulated Parenteral Antimalarial Drug
Autores principales: | Lee, Julia, Krajden, Sigmund, Graham, Christopher, Boggild, Andrea K., Pavenski, Katerina, Keystone, Jay S., Kain, Kevin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285266/ https://www.ncbi.nlm.nih.gov/pubmed/25531800 http://dx.doi.org/10.3201/eid2101.140147 |
Ejemplares similares
-
A case of severe intravascular hemolysis in a young girl
por: Shastry, Shamee, et al.
Publicado: (2011) -
“Hemolysis, or not Hemolysis, that is the Question”. Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency
por: Sgherza, Nicola, et al.
Publicado: (2020) -
Update on Cases of Delayed Hemolysis After Parenteral Artesunate Therapy for Malaria — United States, 2008 and 2013
por: Paczkowski, Magdalena M., et al.
Publicado: (2014) -
Aluminum phosphide poisoning and development of hemolysis and methemoglobinemia
por: Sanaei-Zadeh, Hossein
Publicado: (2012) -
Asymmetric Dimethylarginine in Adult Falciparum Malaria: Relationships With Disease Severity, Antimalarial Treatment, Hemolysis, and Inflammation
por: Barber, Bridget E., et al.
Publicado: (2016)